Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03980574 · ClinicalTrials.gov registry record · NA

Dietary Supplementation in Heart Failure

A NA study, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03980574 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03980574, a NA study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

A single-center, double-blind, placebo-controlled, cross-over study pilot study comparing R Drink vs. placebo in 60 heart failure patients. Half of the participants will also have diabetes mellitus. The 60 patients will be distributed among three arms. Total distance walked in six minutes and hospital readmission rates will be examined. Eligible heart failure patients include those with systolic or diastolic heart failure and diabetes mellitus can be Type I or II. All patients will continue on their standard heart failure and diabetes therapies while they participate in the study.

Interventions

  • DIETARY_SUPPLEMENT R Drink

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-04-01
Est. Completion 2020-06-29
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT03980574

The ClinicalTrials.gov registry entry for NCT03980574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which R Drink is the first listed.

NCT03980574 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03980574 about?

NCT03980574 is a clinical study titled "Dietary Supplementation in Heart Failure". A single-center, double-blind, placebo-controlled, cross-over study pilot study comparing R Drink vs. placebo in 60 heart failure patients. Half of the participants will also have diabetes mellitus. The 60 patients will be distributed among three arms. Total distance walked in six minutes and hospit...

What is the current status of trial NCT03980574?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-04-01. Estimated completion is 2020-06-29.

What interventions are being tested in trial NCT03980574?

The interventions under investigation include: R Drink (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03980574?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.